English

More about this topic

Economy

Which European economy stands to suffer the most from US tariffs?

One-fifth of the EU’s exports are heading to the US. Tariffs on the carmaking sector hit the German economy the most, but potential tariffs on the pharmaceutical one could cost substantially to the Irish economy.

Markets

US copper prices soar after Trump threatens 50% tariff on imports

The 50% duty would match the rate placed on steel and aluminium imports. The president also said he plans to impose a tariff of up to 200% on pharmaceutical drugs.

India

Death toll rises to 39 after blast at pharmaceutical factory in India

The massive explosion and fire at Sigachi Industries' chemical factory in the southern state of Telangana also injured 34 people, officials said.

Health news

Police seize €57 million in black market medicines, weight loss drugs

Interpol cited a concerning rise in demand for unauthorised weight loss drugs and peptide supplements in Europe and other wealthy regions.

ADVERTISEMENT

Health news

Novo Nordisk CEO steps down amid competition for weight loss drugs

Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017, joined the firm in 1991.

Healthcare

Which countries in Europe pay the most for medicines?

Europeans pay different prices for medicines based on where exactly they live, but they spend way less than the US does.

Business

Novo Nordisk cuts forecast as weight-loss drug competition heats up

Novo Nordisk shares jumped following stronger-than-expected first-quarter earnings, despite the company lowering its growth outlook for 2025 amid intensifying competition in the weight-loss drug markets.

Health news

EU Commission slams first US step towards pharmaceutical tariffs

The EU executive has condemned a US probe into pharmaceutical tariffs, warning that proposed duties could disrupt transatlantic trade.

Health news

NGOs warn of Big Pharma’s influence on EU drug reform

Several major organisations are suspicious that recent lobbying efforts by pharmaceutical companies could sway the upcoming EU pharmaceutical reform talks in favour of innovation arguments at the expense of patient access.

Health news

EU holds firm on pharma reform proposal despite industry pressure

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting pressure from the pharmaceutical industry concerned about potential tariffs and the sector’s competitiveness.

Business

Swiss pharma giant Roche pledges to invest €47 billion in the US

The investment plans include new R&D sites in four US states and creating more than 12,000 jobs, according to the Swiss pharmaceutical company.

Economy

US moves ahead with tariffs - launching pharma and chip investigations

The Trump administration has taken its next steps toward imposing more tariffs on key imports, launching investigations into imports of computer chips, chip making equipment and pharmaceuticals.

Health news

Agency flags risks to nuclear medicines from dependency on Russia, US

Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU's radiopharmaceutical sector, according to the European Medicines Agency (EMA).

Business

New tariffs from the US are about to hit the pharmaceutical sector

Despite sparking global-market turmoil with last week’s announcement, the US President is promising new tariffs, now targeting the previously exempted pharmaceutical sector.

Health news

Pharma companies ask EU Commission to negotiate with US over tariffs

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs and other medical products.

Europe News

Did pharma sector dodge Trump’s tariffs? The EU's not so sure

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.

Markets

Novo Nordisk shares post the biggest monthly decline since 2002

Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several disappointing trial results. However, analysts remain optimistic about the shares, forecasting a potential price upside of up to 60% over the next 12 months.

Health news

Tariff treatment: Six diagnoses for EU pharma sector amid US trade war

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.

Europe News

Commission to push 'buy European' in new critical medicines act

The European Commission has proposed new rules aimed at strengthening the security of supply and availability of critical medicines, prioritising EU-based suppliers in public procurement.

Healthcare

Which critical medicines are in short supply in the EU?

The drug shortages are the result of manufacturing problems, increased demand, and other issues.